Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-03-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921016004 |
| _version_ | 1818910096138174464 |
|---|---|
| author | Jyotsna Ghosh Sam Kant Isabel Villegas Kastner Duvuru Geetha |
| author_facet | Jyotsna Ghosh Sam Kant Isabel Villegas Kastner Duvuru Geetha |
| author_sort | Jyotsna Ghosh |
| collection | DOAJ |
| first_indexed | 2024-12-19T22:37:22Z |
| format | Article |
| id | doaj.art-1276bfe2ac5c4d1c8b308525e06a4b5b |
| institution | Directory Open Access Journal |
| issn | 2468-0249 |
| language | English |
| last_indexed | 2024-12-19T22:37:22Z |
| publishDate | 2022-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj.art-1276bfe2ac5c4d1c8b308525e06a4b5b2022-12-21T20:03:10ZengElsevierKidney International Reports2468-02492022-03-0173651652Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody VasculitisJyotsna Ghosh0Sam Kant1Isabel Villegas Kastner2Duvuru Geetha3Division of Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USADivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USADivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USADivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Correspondence: Duvuru Geetha, Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.http://www.sciencedirect.com/science/article/pii/S2468024921016004 |
| spellingShingle | Jyotsna Ghosh Sam Kant Isabel Villegas Kastner Duvuru Geetha Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis Kidney International Reports |
| title | Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis |
| title_full | Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis |
| title_fullStr | Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis |
| title_full_unstemmed | Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis |
| title_short | Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis |
| title_sort | bamlanivimab decreases severe outcomes of sars cov 2 infection in patients with antineutrophil cytoplasmic antibody vasculitis |
| url | http://www.sciencedirect.com/science/article/pii/S2468024921016004 |
| work_keys_str_mv | AT jyotsnaghosh bamlanivimabdecreasessevereoutcomesofsarscov2infectioninpatientswithantineutrophilcytoplasmicantibodyvasculitis AT samkant bamlanivimabdecreasessevereoutcomesofsarscov2infectioninpatientswithantineutrophilcytoplasmicantibodyvasculitis AT isabelvillegaskastner bamlanivimabdecreasessevereoutcomesofsarscov2infectioninpatientswithantineutrophilcytoplasmicantibodyvasculitis AT duvurugeetha bamlanivimabdecreasessevereoutcomesofsarscov2infectioninpatientswithantineutrophilcytoplasmicantibodyvasculitis |